Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026)

Geron's (GERN) quarterly Change in Acquisitions & Divestments came in at $86.6 million in Q1 2026, down 12.39% year-on-year from $98.9 million in Q1 2025, and down 30.89% quarter-over-quarter from $125.4 million in Q4 2025.

Geron (GERN) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Geron has disclosed Change in Acquisitions & Divestments across 17 years of filings, most recently posting $86.6 million for Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $86.6 million, down 12.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $399.5 million (up 7.95% YoY), and the FY2025 annual result was $411.7 million, up 10.79% from the prior year.
  • Change in Acquisitions & Divestments came in at $86.6 million for Q1 2026 at Geron, down from $125.4 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $179.8 million in Q4 2022 to a low of $41.8 million in Q2 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $86.6 million (2026), against an average of $87.4 million.
  • Across the five-year window, Change in Acquisitions & Divestments soared 159.0% in 2022 and tumbled 64.68% in 2023, its largest moves.
  • Geron's Change in Acquisitions & Divestments stood at $179.8 million in 2022, then sank by 64.68% to $63.5 million in 2023, then climbed by 27.78% to $81.1 million in 2024, then surged by 54.51% to $125.4 million in 2025, then plunged by 30.89% to $86.6 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $86.6 million (Q1 2026), $125.4 million (Q4 2025), and $90.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Geron 729,618.77 729,618.77 -

Historic Data

Download Data
DateValue
Mar 31, 2026 86.63 Mn
Mar 31, 2026 86.63 Mn
Dec 31, 2025 125.36 Mn
Dec 31, 2025 125.36 Mn
Sep 30, 2025 90.29 Mn
Sep 30, 2025 90.29 Mn
Jun 30, 2025 97.18 Mn
Jun 30, 2025 97.18 Mn
Mar 31, 2025 98.88 Mn
Mar 31, 2025 98.88 Mn
Dec 31, 2024 81.14 Mn
Dec 31, 2024 81.14 Mn
Sep 30, 2024 65.25 Mn
Sep 30, 2024 65.25 Mn
Jun 30, 2024 124.78 Mn
Jun 30, 2024 124.78 Mn
Mar 31, 2024 100.44 Mn
Mar 31, 2024 100.44 Mn
Dec 31, 2023 63.50 Mn
Dec 31, 2023 63.50 Mn